EBITDA

A Manhattan skyscraper is getting super-insulating windows to dodge climate fines, slash energy use by 20%, and boost tenant comfort. Here’s how.

The University of Florida unveils its new Mondo Super X 720 track, a high-tech marvel fueling record hopes at the prestigious Tom Jones Memorial Invitational.

Panasonic's new TOUGHBOOK 56 brings AI, Wi-Fi 7, and unmatched modularity to the most demanding field environments, setting a new standard for rugged computing.

San Diego's Blacksmith Medicines will present promising data on its FEN1 inhibitor, a new drug targeting a notoriously difficult class of enzymes.

A Pennsylvania firm's acquisition of a New Jersey specialist reflects a larger trend of industry consolidation and a growing demand for enhanced fund security.

A new collaboration integrates Postman's API platform with Microsoft's AI and cloud tools, promising to unify governance and accelerate developer workflows.

As antitrust enforcement surges worldwide, Charles River Associates' strategic re-hire of M&A specialist Hitesh Makhija signals a new front in the talent wars.

PAD is set to go public via a SPAC deal, fueled by contracts with SpaceX and the DoD. We explore the tech, strategy, and market impact of this move.

A four-legged robot powered by physical AI is set to revolutionize heavy industry by tackling the welder shortage and bringing automation to the field.

The new platform moves beyond generative AI, using autonomous 'agents' to manage campaigns, monitor markets, and ensure enterprise-grade security.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.

As Cimpress preps its Q3 results, investors watch to see if record growth can be sustained amid margin pressures in the booming custom print market.

A new coalition launches to combat regulatory hurdles and data rules in the Indo-Pacific, escalating economic tensions and targeting key Asian markets.

A partnership between myTomorrows and Rare Disease Research uses AI to streamline patient access to critical studies, offering new hope for families.

From $1,300 DIY setups to $100K+ labs, a new guide offers a crucial roadmap for researchers navigating the complex, costly world of VR investment.

A new clinical trial validates the Leva Pelvic Health System, offering a discreet, effective at-home treatment for a condition affecting millions of women.

With a massively oversubscribed €600M hybrid note offering, plant-based leader Roquette secures major funding and a huge vote of investor confidence.

A novel immunotherapy tames a potent but toxic cancer-fighting agent by locking it inside tumors, offering new hope for patients with resistant cancers.

As dating app fatigue grows and traditional matchmaking costs soar 26%, a new breed of affordable, human-led services is gaining traction with singles.

Quintara Biosciences launches AmpValue, a $4.99 overnight sequencing service set to disrupt biotech by making advanced, full-length data accessible to all.